1. Home
  2. CGEM vs BAND Comparison

CGEM vs BAND Comparison

Compare CGEM & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • BAND
  • Stock Information
  • Founded
  • CGEM 2016
  • BAND 2000
  • Country
  • CGEM United States
  • BAND United States
  • Employees
  • CGEM N/A
  • BAND N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • BAND Computer Software: Prepackaged Software
  • Sector
  • CGEM Health Care
  • BAND Technology
  • Exchange
  • CGEM Nasdaq
  • BAND Nasdaq
  • Market Cap
  • CGEM 482.7M
  • BAND 473.2M
  • IPO Year
  • CGEM 2021
  • BAND 2017
  • Fundamental
  • Price
  • CGEM $6.45
  • BAND $16.17
  • Analyst Decision
  • CGEM Strong Buy
  • BAND Buy
  • Analyst Count
  • CGEM 8
  • BAND 6
  • Target Price
  • CGEM $27.25
  • BAND $20.80
  • AVG Volume (30 Days)
  • CGEM 525.8K
  • BAND 217.9K
  • Earning Date
  • CGEM 11-06-2025
  • BAND 10-30-2025
  • Dividend Yield
  • CGEM N/A
  • BAND N/A
  • EPS Growth
  • CGEM N/A
  • BAND N/A
  • EPS
  • CGEM N/A
  • BAND N/A
  • Revenue
  • CGEM N/A
  • BAND $758,106,000.00
  • Revenue This Year
  • CGEM N/A
  • BAND $2.48
  • Revenue Next Year
  • CGEM N/A
  • BAND $13.24
  • P/E Ratio
  • CGEM N/A
  • BAND N/A
  • Revenue Growth
  • CGEM N/A
  • BAND 14.51
  • 52 Week Low
  • CGEM $6.44
  • BAND $11.33
  • 52 Week High
  • CGEM $18.62
  • BAND $23.00
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 36.01
  • BAND 63.46
  • Support Level
  • CGEM $6.44
  • BAND $14.97
  • Resistance Level
  • CGEM $7.82
  • BAND $16.49
  • Average True Range (ATR)
  • CGEM 0.43
  • BAND 0.59
  • MACD
  • CGEM -0.11
  • BAND 0.14
  • Stochastic Oscillator
  • CGEM 4.55
  • BAND 88.03

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

Share on Social Networks: